ProPhase Labs, Inc.
PRPH
$0.05
$0.0120.53%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 478.00K | 784.00K | 883.00K | 1.25M | 1.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 478.00K | 784.00K | 883.00K | 1.25M | 1.43M |
| Cost of Revenue | 311.00K | 537.00K | 1.01M | 513.00K | 905.00K |
| Gross Profit | 167.00K | 247.00K | -123.00K | 734.00K | 526.00K |
| SG&A Expenses | 2.77M | 5.97M | 4.64M | 4.62M | 4.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.08M | 6.51M | 5.65M | 5.14M | 5.09M |
| Operating Income | -2.61M | -5.73M | -4.76M | -3.89M | -3.66M |
| Income Before Tax | -3.98M | -8.02M | -7.00M | -3.69M | -4.68M |
| Income Tax Expenses | 1.37M | -622.00K | -157.00K | 779.00K | -- |
| Earnings from Continuing Operations | -5.35M | -7.40M | -6.84M | -4.47M | -4.68M |
| Earnings from Discontinued Operations | -- | 0.00 | -- | -- | 8.64M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.35M | -7.40M | -6.84M | -4.47M | 3.97M |
| EBIT | -2.61M | -5.73M | -4.76M | -3.89M | -3.66M |
| EBITDA | -1.64M | -4.76M | -3.73M | -2.55M | -2.18M |
| EPS Basic | -0.43 | -0.33 | -1.65 | -1.08 | 1.13 |
| Normalized Basic EPS | -0.19 | -0.26 | -1.09 | -0.39 | -0.75 |
| EPS Diluted | -0.43 | -0.33 | -1.65 | -1.10 | 1.12 |
| Normalized Diluted EPS | -0.19 | -0.26 | -1.09 | -0.39 | -0.75 |
| Average Basic Shares Outstanding | 12.32M | 22.12M | 4.15M | 4.15M | 3.52M |
| Average Diluted Shares Outstanding | 12.32M | 22.12M | 4.15M | 4.15M | 3.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |